Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Enterprise Value (2024 - 2026)

Camp4 Therapeutics' Enterprise Value history spans 3 years, with the latest figure at -$110.9 million for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 73.12% to -$110.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$110.9 million, a 73.12% decrease, with the full-year FY2025 number at -$110.9 million, down 73.12% from a year prior.
  • Enterprise Value hit -$110.9 million in Q4 2025 for Camp4 Therapeutics, down from -$75.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for CAMP hit a ceiling of -$2.5 million in Q3 2024 and a floor of -$110.9 million in Q4 2025.
  • Historically, Enterprise Value has averaged -$53.8 million across 3 years, with a median of -$49.9 million in 2023.
  • Biggest five-year swings in Enterprise Value: surged 94.99% in 2024 and later plummeted 2878.64% in 2025.
  • Tracing CAMP's Enterprise Value over 3 years: stood at -$38.4 million in 2023, then crashed by 66.86% to -$64.0 million in 2024, then plummeted by 73.12% to -$110.9 million in 2025.
  • Business Quant data shows Enterprise Value for CAMP at -$110.9 million in Q4 2025, -$75.3 million in Q3 2025, and -$39.1 million in Q2 2025.